SCHEMBL8276502

SCHEMBL8276502

Nc1ncnc2cc(C(=O)O)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.48
PI4KA P42356 2/20 0.47
PI4K2B Q8TCG2 2/20 0.47
PI4K2A Q9BTU6 2/20 0.47
PI4KB Q9UBF8 2/20 0.47
GABRP O00591 2/20 0.44
GABRD O14764 2/20 0.44
GABRA1 P14867 2/20 0.44
GABRB1 P18505 2/20 0.44
GABRG2 P18507 2/20 0.44
GABRB3 P28472 2/20 0.44
GABRA5 P31644 2/20 0.44
GABRA3 P34903 2/20 0.44
GABRA2 P47869 2/20 0.44
GABRB2 P47870 2/20 0.44
GABRA4 P48169 2/20 0.44
GABRE P78334 2/20 0.44
GABRA6 Q16445 2/20 0.44
GABRG1 Q8N1C3 2/20 0.44
GABRG3 Q99928 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3964347 0.86 MAP4K4 (0.51) PI4KAPI4K2BPI4K2API4KBLIMK1
SCHEMBL8276504 0.81 CSNK2A1 (0.48) XDHPI4KAPI4K2BPI4K2API4KB
SCHEMBL6768352 0.81 TDP1 (0.43) KDM4ERECQLTDP1NPC1RAB9A
SCHEMBL16447569 0.79 TDP1 (0.54) KDM4ETDP1NPC1RAB9AHKDC1
SCHEMBL4968804 0.79 PDE4A (0.47) KDM4ERECQLTDP1NPC1RAB9A
4-Aminoquinazoline SCHEMBL28259933 0.78 PI4KA (0.70) XDHPI4KAPI4K2BPI4K2API4KB
Hydrochloric Acid SCHEMBL6332115 0.78 PDE4A (0.46) KDM4ERECQLTDP1NPC1RAB9A
SCHEMBL437621 0.76 NR4A2 (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL14568169 0.74 MAP4K4 (0.68) LIMK1MAP4K4
SCHEMBL4431055 0.74 MAP4K4 (0.54) PI4KAPI4K2BPI4K2API4KBLIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773786-B1 FIVE-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-04-26 EP disclosed
EP-1841504-B1 SUBSTITUTED BIARYL COMPOUNDS AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-11-19 EP disclosed
EP-1773775-B1 SIX-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-08-17 EP disclosed
WO-2005123050-A2 FIVE-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-12-29 WO disclosed